A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
N
Nabekura T, Yamaki T, Hiroi T, Ueno K, Kitagawa S. Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals. Pharmacol Res 2010; 61:259-63.
Nabekura T, Yamaki T, Kitagawa S. Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1. Eur J Pharmacol 2008; 600:45-9.
Nabekura T, Yamaki T, Ueno K, Kitagawa S. Effects of plant sterols on human multidrug transporters ABCB1 and ABCC1. Biochem Biophys Res Commun 2008; 369:363-8.
Nacmias B, Bagnoli S, Tedde A et al. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer’s disease and longevity. Arch Gerontol Geriatr 2007; 45:201-6.
Nadif R, Kleeberger SR, Kauffmann F. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy 2006; 36:1104-6.
Nadif R, Mintz M, Jedlicka A, Bertrand JP, Kleeberger SR, Kauffmann F. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res 2005; 39:1345-50.
Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4:481-508.
Naesens M, Kuypers DR, Verbeke K, Vanrenterghem Y. Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients. Transplantation 2006; 82:1074-84.
Naesens M, Lerut E, de Jonge H, van Damme B, Vanrenterghem Y, Kuypers DR. Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol 2009; 20:2468-80.
Nagai F, Hiyoshi Y, Sugimachi K, Tamura HO. Cytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines. Biol Pharm Bull 2002; 25:383-5.
Nagai F, Kato E, Tamura HO. Oxidative stress induces GSTP1 and CYP3A4 expression in the human erythroleukemia cell line, K562. Biol Pharm Bull 2004; 27:492-5.
Nagai F, Shimizu M, Sakamoto T, Kobayashi T, Tamura H. Changes in the expression of cytochrome P450 genes in hemin-induced differentiated K562 cells. Biol Pharm Bull 2007; 30:1954-7.
Nagai M, Fukamachi T, Tsujimoto M et al. Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol Pharm Bull 2009; 32:105-9.
Nagai S, Takenaka K, Nachagari D et al. Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity. Cancer Res 2011; 71:1781-91.
Naganuma M, Shiga T, Nishikata K, Tsuchiya T, Kasanuki H, Fujii E. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy. J Cardiovasc Pharmacol Ther 2001; 6:363-7.
Naganuma T, Nakayama T, Sato N et al. A haplotype-based case-control study examining human extracellular superoxide dismutase gene and essential hypertension. Hypertens Res 2008; 31:1533-40.
Nagaoka R, Iwasaki T, Rokutanda N et al. Tamoxifen activates CYP3A4 and MDR1 genes through steroid and xenobiotic receptor in breast cancer cells. Endocrine 2006; 30:261-8.
Nagar S, Saha A. Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer. J Comput Chem 2010; 31:2342-53.
Nagar S, Saha A. Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies. Eur J Med Chem 2010; 45:4307-15.
Nagar S, Walther S, Blanchard RL. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Mol Pharmacol 2006; 69:2084-92.
Nagar S, Zalatoris JJ, Blanchard RL. Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 2004; 14:487-99.
Nagarajan G, Tsai YJ, Chen CY, Chang CF. Developmental expression of genes involved in neural estrogen biosynthesis and signaling in the brain of the orange-spotted grouper Epinephelus coioides during gonadal sex differentiation. J Steroid Biochem Mol Biol 2011. doi:10. 1016/j. jsbmb. 2011. 03. 021.
Nagarajan RP, Costello JF. Molecular epigenetics and genetics in neuro-oncology. Neurotherapeutics 2009; 6:436-46.
Nagashima S, Hondo T, Nagata H et al. Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitors. Bioorg Med Chem 2009; 17:6926-36.
Nagata T, Takahashi Y, Ishii Y et al. Profiling of genes differentially expressed between fetal liver and postnatal liver using high-density oligonucleotide DNA array. Int J Mol Med 2003; 11:713-21.
Nagatomo Y, Yoshikawa T, Kohno T et al. Effects of beta-blocker therapy on high sensitivity c-reactive protein, oxidative stress, and cardiac function in patients with congestive heart failure. J Card Fail 2007; 13:365-71.
Nagele P, Liggett SB. Genetic Variation, β-blockers, and perioperative myocardial infarction. Anesthesiology 2011; 115:879-90.
Nagelin MH, Srinivasan S, Nadler JL, Hedrick CC. Murine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways. J Biol Chem 2009; 284:31303-14.
Nagila A, Permpongpaiboon T, Tantrarongroj S et al. Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status. Pharmacol Rep 2009; 61:892-8.
Nagy J, Schipper HG, Koopmans RP, Butter JJ, van Boxtel CJ, Kager PA. Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. Am J Trop Med Hyg 2002; 66:260-3.
Nagy LD, Mocny CS, Diffenderfer LE et al. Substituted imidazole of 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Inactivates cytochrome P450 2D6 by protein adduction. Drug Metab Dispos 2011; 39:974-83.
Nagy N, Freudenberger T, Melchior-Becker A et al. Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation 2010; 122:2313-22.
Nahid MA, Rivera M, Lucas A, Chan EK, Kesavalu L. Polymicrobial infection with periodontal pathogens specifically enhances microRNA miR-146a in ApoE-/- mice during experimental periodontal disease. Infect Immun 2011; 79:1597-605.
Nahrstedt A, Butterweck V. Lessons Learned from Herbal Medicinal Products: The Example of St. John’s Wort (perpendicular). J Nat Prod 2010; 73:1015-21.
Naidu R, Har YC, Taib NA. Genetic polymorphisms of Paraoxonase 1 (PON1) gene: Association between L55M or Q192R with breast cancer risk and clinico-pathological parameters. Pathol Oncol Res 2010. doi:10. 1007/s12253-010-9267-5.
Naik RS, Hartmann J, Kiewert C, Duysen EG, Lockridge O, Klein J. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice. J Pharm Pharm Sci 2009; 12:79-85.
Naiman K, Frei E, Stiborova M. Identification of rat cytochromes P450 metabolizing N-(2-methoxyphenyl)hydroxylamine, a human metabolite of the environmental pollutants and carcinogens o-anisidine and o-nitroanisole. Neuro Endocrinol Lett 2010; 31 Suppl 2:36-45.
Nair BC, Vallabhaneni S, Tekmal RR, Vadlamudi RK. Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells. Breast Cancer Res 2011; 13:80.
Nair DR, Morris HH. Potential fluconazole-induced carbamazepine toxicity. Ann Pharmacother 1999; 33:790-2.
Nair RP, Duffin KC, Helms C et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009; 41:199-204.
Nair RP, Stuart PE, Nistor I et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006; 78:827-51.
Nair VD, Foster BC, Thor Arnason J, Mills EJ, Kanfer I. In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato. Phytomedicine 2007; 14:498-507.
Nait Chabane M, Al Ahmad A, Peluso J, Muller CD, Ubeaud G. Quercetin and naringenin transport across human intestinal Caco-2 cells. J Pharm Pharmacol 2009; 61:1473-83.
Naito T, Takashina Y, Yamamoto K et al. CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone. J Clin Pharmacol 2011; 51:1529-38.
Naj AC, West M, Rich SS et al. Association of scavenger receptor class B type I polymorphisms with subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Genet 2010; 3:47-52.
Najafi-Shoushtari SH, Kristo F, Li Y et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010; 328:1566-9.
Najar IA, Sharma SC, Singh GD, Koul S, Gupta PN, Javed S, Johri RK. Involvement of P-glycoprotein and CYP 3A4 in the enhancement of etoposide bioavailability by a piperine analogue. Chem Biol Interact 2011; 190:84-90.
Najib J. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Clin Ther 2006; 28:491-516.
Nakade S, Yamauchi A, Komaba J et al. Effect of clarithromycin on the pharmacokinetics of pranlukast in healthy volunteers. Drug Metab Pharmacokinet 2008; 23:428-33.
Nakagami H, Morishita R. Obesity and gastrointestinal hormones-dual effect of angiotensin II receptor blockade and a partial agonist of PPAR-γ. Curr Vasc Pharmacol 2011; 9:162-6.
Nakagami T, Yasui-Furukori N, Saito M et al. Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction. J Clin Psychopharmacol 2005; 25:89-91.
Nakagami T, Yasui-Furukori N, Saito M, Tateishi T, Kaneo S. Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition. Clin Pharmacol Ther 2005; 78:43-51.
Nakagawa H, Toyoda Y, Wakabayashi-Nakao K, Tamaki H, Osumi M, Ishikawa T. Ubiquitin-mediated proteasomal degradation of ABC transporters: a new aspect of genetic polymorphisms and clinical impacts. J Pharm Sci 2011; 100:3602-19.
Nakagawa-Goto K, Chang PC, Lai CY et al. Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analogues. J Med Chem 2010; 53:6699-705.
Nakagawa-Goto K, Wu PC, Lai CY et al. Antitumor agents. 284. New desmosdumotin B analogues with bicyclic B-ring as cytotoxic and antitubulin agents. J Med Chem 2011; 54:1244-55.
Nakai K, Tsuboi J, Okabayashi H et al. Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients. Pharmacogenomics 2007; 8:713-9.
Nakajima H, Nakanishi T, Naba H et al. Studies on the metabolic fate of M17055, a novel diuretic (6). Assessment for drug-drug interactions of M17055 in metabolism, distribution and excretion. Xenobiotica 2002; 32:1161-72.
Nakajima H, Nakanishi T, Nakai K et al. Studies on the metabolic fate of M17055, a novel diuretic (4): species difference in metabolic pathway and identification of human CYP isoform responsible for the metabolism of M17055. Drug Metab Pharmacokinet 2002; 17:60-74.
Nakajima K, Tanaka Y, Nomiyama T et al. Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes. Diabetes 2002; 51:238-42.
Nakajima M, Fujiki Y, Kyo S et al. Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1. J Clin Pharmacol 2005; 45:674-82.
Nakajima M, Fukami T, Yamanaka H et al. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther 2006; 80:282-97.
Nakajima M, Hattori E, Yamada K et al. Association and synergistic interaction between promoter variants of the DRD4 gene in Japanese schizophrenics. J Hum Genet 2007; 52:86-91.
Nakajima M, Inoue T, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Drug Metab Dispos 1998; 26:261-6.
Nakajima M, Kobayashi K, Oshima K et al. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes. Xenobiotica 1999; 29:885-98.
Nakajima M, Kobayashi K, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y. Involvement of CYP1A2 in mexiletine metabolism. Br J Clin Pharmacol 1998; 46:55-62.
Nakajima M, Komagata S, Fujiki Y et al. Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients. Pharmacogenet Genomics 2007; 17:431-45.
Nakajima M, Kwon JT, Tanaka N et al. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther 2001; 69:72-8.
Nakajima M, Nakamura S, Tokudome S, Shimada N, Yamazaki H, Yokoi T. Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs. Drug Metab Dispos 1999; 27:1381-91.
Nakajima M, Ohyama K, Nakamura S, Shimada N, Yamazaki H, Yokoi T. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes. Drug Metab Dispos 1999; 27:792-7.
Nakajima M, Sawada H, Yamada Y et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 1999; 85:1894-902.
Nakajima M, Suzuki M, Yamaji R et al. Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds. Xenobiotica 1999; 29:1191-202.
Nakajima M, Suzuki T, Sasaki T et al. Effects of chronic administration of glucocorticoid on midazolam pharmacokinetics in humans. Ther Drug Monit 1999; 21:507-13.
Nakajima M, Tane K, Nakamura S, Shimada N, Yamazaki H, Yokoi T. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities. J Pharm Sci 2002; 91:952-63.
Nakajima M, Yamamoto T, Nunoya K et al. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 1996; 24:1212-7.
Nakajima M, Yoshida R, Fukami T, McLeod HL, Yokoi T. Novel human CYP2A6 alleles confound gene deletion analysis. FEBS Lett 2004; 569:75-81.
Nakajima M, Yoshida R, Shimada N, Yamazaki H, Yokoi T. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Metab Dispos 2001; 29:1110-3.
Nakajima T, Elovaara E, Gonzalez FJ, Gelboin HV, Vainio H, Aoyama T. Characterization of the human cytochrome P450 isozymes responsible for styrene metabolism. IARC Sci Publ 1993; 127:101-8.
Nakajima T, Elovaara E, Gonzalez FJ et al. Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem Res Toxicol 1994; 7:891-6.
Nakajima T, Kimura A. Genetic factors that confer sensitivity to HAART in HIV-infected subjects: implication of a benefit of an earlier initiation of HAART. Pharmacogenomics 2008; 9:1347-51.
Nakajima T, Wang RS, Elovaara E et al. Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. Biochem Pharmacol 1997; 53:271-7.
Nakajima T, Wooding S, Sakagami T et al. Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet 2004; 74:898-916.
Nakajima Y, Saito Y, Shiseki K et al. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients. Eur J Clin Pharmacol 2005; 61:25-34.
Nakajima Y, Yoshitani T, Fukushima-Uesaka H et al. Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer. Clin Pharmacol Ther 2006; 80:179-91.
Nakamoto K, Wang S, Jenison RD et al. Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene. BMC Genet 2006; 7:29.
Nakamura A, Hirota T, Morino A et al. Cytochrome P450 isoforms responsible for the N-deethylation and cyclohexane-hydroxylation of NS-21. Xenobiotica 1999; 29:243-52.
Nakamura A, Tougou K, Kitazumi H et al. Effects of etodolac on P450 isoform-specific activities in human hepatic microsomes. Arzneimittelforschung 2005; 55:744-8.
Nakamura A, Tougou K, Kitazumi H et al. Effects of irsogladine on P450-isoform specific activities in human hepatic microsomes. Arzneimittelforschung 2006; 56:547-52.
Nakamura E, Kozaki K, Tsuda H et al. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma. Cancer Sci 2008; 99:1390-400.
Nakamura H, Ariyoshi N, Okada K, Nakasa H, Nakazawa K, Kitada M. CYP1A1 is a major enzyme responsible for the metabolism of granisetron in human liver microsomes. Curr Drug Metab 2005; 6:469-80.
Nakamura H, Nakasa H, Ishii I et al. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes. Drug Metab Dispos 2002; 30:534-40.
Nakamura H, Ohtsuka T, Enomoto H et al. Effect of levofloxacin on theophylline clearance during theophylline and clarithromycin combination therapy. Ann Pharmacother 2001; 35:691-3.
Nakamura H, Torimoto N, Ishii I et al. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids. Drug Metab Dispos 2003; 31:432-8.
Nakamura K, Ariyoshi N, Iwatsubo T et al. Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes. Biol Pharm Bull 2005; 28:882-5.
Nakamura K, Sekine Y, Takei N et al. An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis. Neurosci Lett 2009; 455:120-3.
Nakamura K, Watanabe A, Okudaira N, Okazaki O, Sudo K. Effect of ion suppression on judgment of enzyme inhibition and avoidance of error by utilizing a stable isotope-labeled probe substrate: example of CYP3A4 inhibition with [13C4,15N] labeled midazolam as a substrate. Drug Metab Pharmacokinet 2007; 22:113-8.
Nakamura K, Yokoi T, Inoue K et al. CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human liver microsomes. Pharmacogenetics 1996; 6:449-57.
Nakamura K, Yokoi T, Kodama T et al. Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes. J Pharmacol Exp Ther 1998; 284:437-42.
Nakamura M, Tanaka E, Misawa S, Shimada T, Imaoka S, Funae Y. Trimethadione metabolism, a useful indicator for assessing hepatic drug-oxidizing capacity. Biochem Pharmacol 1994; 47:247-51.
Nakamura M, Yasunami M, Kondo H et al. Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): The HLA-DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC. Hepatol Res 2010; 40:494-504.
Nakamura S, Tezuka Y, Ushiyama A et al. Ipso substitution of bisphenol A catalyzed by microsomal cytochrome P450 and enhancement of estrogenic activity. Toxicol Lett 2011; 203:92-5.
Nakamura T, Okamura N, Yagi M et al. Effects of ABCB1 3435C>T genotype on serum levels of cortisol and aldosterone in women with normal menstrual cycles. Genet Mol Res 2009; 8:397-403.
Nakamura T, Sakaeda T, Horinouchi M et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 2002; 71:297-303.
Nakamura T, Yamamoto E, Kataoka K et al. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Hypertension 2008; 51:296-301.
Nakamura Y. Chemoprevention by isothiocyanates: molecular basis of apoptosis induction. Forum Nutr 2009; 61:170-81.
Nakamura Y, Kanazawa M, Liyanage R et al. Effect of white wheat bread containing sugar beet fiber on serum lipids and hepatic mRNA in rats fed on a cholesterol-free diet. Biosci Biotechnol Biochem 2009; 73:1280-5.
Nakamura Y, Satoh F, Morimoto R et al. 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J Clin Endocrinol Metab 2011; 96:1272-8.
Nakamura Y, Soda H, Oka M et al. Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia. J Thorac Oncol 2011; 6:121-7.
Nakanishi H, Yamashiro K, Yamada R et al. Joint effect of cigarette smoking and CFH and LOC387715/HTRA1 polymorphisms on polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2010; 51:6183-7.
Nakanishi K, Saitoh S. Clinical and genetic characteristics of patients with type 1 diabetes associated with interferon therapy. Diabetes Care 2011; 34:471-3.
Nakanishi S, Yamane K, Ohishi W et al. Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans. Diabetes Res Clin Pract 2008; 81:381-5.
Nakanishi T, Chumsri S, Khakpour N et al. Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling. Br J Cancer 2010; 102:815-26.
Nakano T, Sekine S, Ito K, Horie T. Correlation between apical localization of Abcc2/Mrp2 and phosphorylation status of ezrin in rat intestine. Drug Metab Dispos 2009; 37:1521-7.
Nakao F, Ihara K, Kusuhara K et al. Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J Allergy Clin Immunol 2001; 107:499-504.
Nakao M, Muramoto Y, Hisadome M et al. The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6. Eur J Clin Pharmacol 2007; 63:345-53.
Nakao M, Yokota S, Iwai T et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996; 10:1911-8.
Nakasa H, Nakamura H, Ono S et al. Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data. Eur J Clin Pharmacol 1998; 54:177-83.
Nakase T, Mizuno T, Harada S et al. Angiotensinogen gene polymorphism as a risk factor for ischemic stroke. J Clin Neurosci 2007; 14:943-7.
Nakashima A, Kawashita H, Masuda N et al. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes. Xenobiotica 2005; 35:589-602.
Nakashima D, Takama H, Ogasawara Y et al. Effect of cinacalcet hydrochloride, a new calcimimetic agent, on the pharmacokinetics of dextromethorphan: in vitro and clinical studies. J Clin Pharmacol 2007; 47:1311-9.
Nakatsuka A, Nagai M, Yabe H et al. Effect of clarithromycin on the pharmacokinetics of cabergoline in healthy controls and in patients with Parkinson’s disease. J Pharmacol Sci 2006; 100:59-64.
Nakatsuma A, Fukami T, Suzuki T, Furuishi T, Tomono K, Hidaka S. Effects of kaempferol on the mechanisms of drug resistance in the human glioblastoma cell line T98G. Pharmazie 2010; 65:379-83.
Nakaya K, Ayaori M, Uto-Kondo H et al. Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo. Atherosclerosis 2010; 213:135-41.
Nakayama K, Nitto T, Inoue T, Node K. Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes. Life Sci 2008; 83:339-45.
Nakayama K, Soemantri A, Jin F et al. Identification of novel functional variants of the melanocortin 1 receptor gene originated from Asians. Hum Genet 2006; 119:322-30.
Nakayama M, Yasue H, Yoshimura M et al. T-786→C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99:2864-70.
Nakayama M, Yoshimura M, Sakamoto T et al. Synergistic interaction of T-786→C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm. Pharmacogenetics 2003; 13:683-8.
Nakayama S, Torikoshi Y, Takahashi T et al. Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells. Breast Cancer Res 2009; 11:12.
Nakayama T, Soma M, Rehemudula D et al. Association of 5’ upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. Am J Hypertens 2000; 13:1263-7.
Nakayama T, Soma M, Saito S et al. Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. Am Heart J 2002; 143:797-801.
Nakazato K, Yoshida Y, Takemori K, Kobayashi K, Sakamoto A. Expressions of genes encoding drug-metabolizing enzymes are altered after sevoflurane, isoflurane, propofol or dexmedetomidine anesthesia. Biomed Res 2009; 30:17-24.
Nakhoul FM, Miller-Lotan R, Awaad H, Asleh R, Levy AP. Hypothesis-haptoglobin genotype and diabetic nephropathy. Nat Clin Pract Nephrol 2007; 3:339-44.
Nalda-Molina R, Valenzuela B, Ramon-Lopez A, Miguel-Lillo B, Soto-Matos A, Perez-Ruixo JJ. Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects. Cancer Chemother Pharmacol 2009; 64:97-108.
Nallani SC, Genter MB, Desai PB. Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel. Cancer Chemother Pharmacol 2001; 48:115-22.
Nallani SC, Glauser TA, Hariparsad N et al. Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate. Epilepsia 2003; 44:1521-8.
Nallani SC, Goodwin B, Buckley AR, Buckley DJ, Desai PB. Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes. Cancer Chemother Pharmacol 2004; 54:219-29.
Nam DT, Arseneault M, Murthy V, Ramassamy C. Potential role of acrolein in neurodegeneration and in Alzheimer’s disease. Curr Mol Pharmacol 2010; 3:66-78.
Nam H, Kim J, Park J et al. Expression profile of the stem cell markers in human Hertwig’s epithelial root sheath/Epithelial rests of Malassez cells. Mol Cells 2011; 31:355-60.
Nam RK, Zhang WW, Trachtenberg J et al. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol Biomarkers Prev 2003; 12:1429-37.
Namazi S, Monabati A, Ardeshir-Rouhani-Fard S, Azarpira N. Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian population. Mol Carcinog 2010; 49:1022-30.
Nambu T, Hamada A, Nakashima R et al. Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia. Biol Pharm Bull 2011; 34:114-9.
Nan Y, Wang R, Zhao S et al. Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice. Lipids Health Dis 2010; 9:124.
Nanji AA, Jokelainen K, Fotouhinia M et al. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. Am J Physiol Gastrointest Liver Physiol 2001; 281:1348-56.
Nannelli A, Chirulli V, Longo V, Gervasi PG. Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 2008; 252:105-12.
Nannelli A, Rossignolo F, Tolando R, Rossato P, Longo V, Gervasi PG. Effect of beta-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig. Toxicology 2009; 265:69-79.
Nannelli A, Rossignolo F, Tolando R et al. Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs. Mol Cell Biochem 2010; 337:133-43.
Nantia EA, Travert C, Manfo FP, Carreau S, Monsees TK, Moundipa PF. Effects of the methanol extract of Basella alba L (Basellaceae) on steroid production in Leydig cells. Int J Mol Sci 2011; 12:376-84.
Naoe T, Tagawa Y, Kiyoi H et al. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy. Leukemia 2002; 16:203-8.
Naoe T, Takeyama K, Yokozawa T et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000; 6:4091-5.
Naoi M, Maruyama W. Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson’s disease. Expert Rev Neurother 2009; 9:1233-50.
Napolioni V, Giannì P, Carpi FM, Predazzi IM, Lucarini N. APOE haplotypes are associated with human longevity in a Central Italy population: Evidence for epistasis with HP 1/2 polymorphism. Clin Chim Acta 2011; 412:1821-4.
Napolioni V, Lucarini N. Gender-specific association of ADA genetic polymorphism with human longevity. Biogerontology 2010; 11:457-62.
Napolioni V, Predazzi IM. Age- and gender-specific association between ADA (22G>A) and TNF-alpha (-308G>A) genetic polymorphisms. Tissue Antigens 2010; 76:311-4.
Napolitano C, Schwartz PJ, Brown AM et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. Cardiovasc Electrophysiol 2000; 11:691-6.
Napper JM, Sollars VE. 17-N-Allylamino-17-demethoxygeldanamycin induces a diverse response in human acute myelogenous cells. Leuk Res 2010; 34:1493-500.
Naraharisetti SB, Lin YS, Rieder MJ et al. Human liver expression of CYP2C8: gender, age, and genotype effects. Drug Metab Dispos 2010; 38:889-93.
Naraim Y, Wyttenbach A, Rankin J, Furlong RA, Rubinsztein DC. A molecular investigation of true dominance in Huntington’s disease. J Med Genet 1999; 36:739-46.
Narain Y, Yip A, Murphy T et al. The ACE gene and Alzheimer’s disease susceptibility. J Med Genet 2000; 37:695-7.
Narang VS, Fraga C, Kumar N et al. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. Am J Physiol Cell Physiol 2008; 295:440-50.
Naranjo CA, Sproule BA, Knoke DM. Metabolic interactions of central nervous system medications and selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 1999; 14 Suppl 2:35-47.
Narasimhan KL, Madhu K, Balpinder K et al. Association of angiotensin converting enzyme and angiotensin type 2 receptor gene polymorphisms with renal damage in posterior urethral valves. J Pediatr Urol 2010; 6:560-6.
Narayan S, Carlson EM, Cheng H et al. Novel second generation analogs of eribulin. Part I: Compounds containing a lipophilic C32 side chain overcome P-glycoprotein susceptibility. Bioorg Med Chem Lett 2011; 21:1630-3.
Narayan S, Jaiswal AS. Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N’-nitro-N-nitrosoguanidine requires p53. J Biol Chem 1997; 272:30619-22.
Nardi V, Azam M, Daley GQ. Mechanisms and implications of imatinib resistance mutations in BCR-ABL. Curr Opin Hematol 2004; 11:35-43.
Nardocci N, Zorzi G, Blau N et al. Neonatal dopa-responsive extrapyramidal syndrome in twins with recessive GTPCH deficiency. Neurology 2003; 60:335-7.
Narducci MG, Scala E, Bresin A et al. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. Blood 2006; 107:1108-15.
Nare B, Wring S, Bacchi C et al. Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis. Antimicrob Agents Chemother 2010; 54:4379-88.
Narimatsu S, Kobayashi N, Masubuchi Y et al. Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes. Chem Biol Interact 2000; 127:73-90.
Narimatsu S, Masubuchi Y, Hosokawa S, Ohmori S, Kitada M, Suzuki T. Involvement of a cytochrome P4502D subfamily in human liver microsomal bunitrolol 4-hydroxylation. Biol Pharm Bull 1994; 17:803-7.
Narimatsu S, Nakata T, Shimizudani T et al. Regio- and stereoselective oxidation of propranolol enantiomers by human CYP2D6, cynomolgus monkey CYP2D17 and marmoset CYP2D19. Chem Biol Interact 2011; 189:146-52.
Narimatsu S, Takemi C, Kuramoto S et al. Stereoselectivity in the oxidation of bufuralol, a chiral substrate, by human cytochrome P450s. Chirality 2003; 15:333-9.
Narimatsu S, Takemi C, Tsuzuki D et al. Stereoselective metabolism of bufuralol racemate and enantiomers in human liver microsomes. J Pharmacol Exp Ther 2002; 303:172-8.
Narimatsu S, Yonemoto R, Saito K et al. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Biochem Pharmacol 2006; 71:1377-85.
Narita I, Goto S, Saito N et al. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. Kidney Int 2003; 64:1050-8.
Naritomi Y, Terashita S, Kagayama A. Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate. Xenobiotica 2004; 34:415-27.
Narumiya K, Metzger R, Bollschweiler E et al. Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer. Pharmacogenomics 2011; 12:205-14.
Nasir J, Duan K, Nichol K et al. Gene structure and map location of the murine homolog of the Huntington-association protein, Hap1. Mammalian Genome 1998; 9:565-70.
Nasir J, Lafuente M, Duan K et al. Human huntingtin-associated protein (HAP-1) gene: genomic organisation and an intragenic polymorphism. Gene 2000; 254:181-7.
Nass N, Schoeps R, Ulbrich-Hofmann R et al. Screening for nutritive peptides that modify cholesterol 7alpha-hydroxylase expression. J Agric Food Chem 2008; 56:4987-94.
Nassar AE, King I, Paris BL et al. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes. Drug Metab Dispos 2009; 37:1922-30.
Nassar MA, Stirling LC, Forlani G et al. Nociceptor-specific gene deletion reveals a major role for Nav1. 7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci USA 2004; 101:12706-11.
Nassr N, Huennemeyer A, Herzog R et al. Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects. Br J Clin Pharmacol 2009; 68:580-7.
Nassr N, Lahu G, von Richter O et al. Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects. Br J Clin Pharmacol 2007; 63:365-70.
Nasu K, Kawano Y, Tsukamoto Y et al. Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target. J Obstet Gynaecol Res 2011; 37:683-95.
Natesh R, Schwager SLU, Sturrock ED, Acharya KR. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003; 421:551-4.
Nath A, Atkins W. Principal component analysis of CYP2C9 and CYP3A4 probe substrate/inhibitor panels. Drug Metab Dispos 2008; 36:2151-5.
Nath A, Fernández C, Lampe JN, Atkins WM. Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4. Arch Biochem Biophys 2008; 474:198-204.
Nath A, Grinkova YV, Sligar SG, Atkins WM. Ligand binding to cytochrome P450 3A4 in phospholipid bilayer nanodiscs: the effect of model membranes. J Biol Chem 2007; 282:28309-20.
Nathanson N, Wilesmith J, Wells GA, Griot C. Bovine spongiform encephalopathy and related diseases. In: Prusiner SB (Ed). Prion biology and diseases. Cold Spring Harbor Laboratory Press, New York, 1999:431-63.
Nathwani SM, Butler S, Fayne D et al. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells. Cancer Chemother Pharmacol 2010; 66:585-96.
National Toxicology Program. Final report on carcinogens background document for styrene. Rep Carcinog Backgr Doc 2008:i-398.
National Toxicology Program. Toxicology and carcinogenesis studies of 2,3’,4,4’,5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (Gavage studies). Natl Toxicol Program Tech Rep Ser 2010:1-174.
Natividad A, Holland MJ, Rockett KA et al. Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation. Hum Mol Genet 2008; 17:323-9.
Natsui K, Mizuno Y, Tani N, Yabuki M, Komuro S. Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes. Eur J Drug Metab Pharmacokinet 2007; 32:233-40.
Navab M, Reddy ST, Anantharamaiah GM et al. Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally. J Lipid Res 2011; 52:1200-10.
Navab M, Reddy ST, van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 2011; 8:222-32.
Navaglia F, Basso D, Zambon CF et al. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals. J Med Genet 2005; 42:503-10.
Navari RM. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. Expert Rev Anticancer Ther 2004; 4:715-24.
Navarro P, Guerrero R, Gallego E et al. Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau. J Neurol Sci 2008; 275:139-44.
Navarro SL, Chen Y, Li L et al. UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables. Drug Metab Dispos 2011; 39:1650-7.
Navas-Acien A, Sharrett AR, Silbergeld EK et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005; 162:1037-49.
Navasumrit P, Ward TH, O’Connor PJ, Nair J, Frank N, Bartsch H. Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA. Mutat Res 2001; 479:81-94.
Naviaux RK, Nguyen KV. POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol 2004; 55:706-12.
Naviaux RK, Nguyen KV. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Ann Neurol 2005; 58:491.
Navikas V, He B, Link J et al. Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996; 119:213-23.
Nawa A, Fujita Hamabe W, Tokuyama S. Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions. Life Sci 2010; 86:402-9.
Nawa A, Fujita-Hamabe W, Nakamoto K, Tokuyama S. Nitric oxide synthase-mediated alteration of intestinal P-glycoprotein under hyperglycemic stress. Yakugaku Zasshi 2011; 131:487-92.
Nawa A, Fujita-Hamabe W, Tokuyama S. Regulatory action of nitric oxide synthase on ileal P-glycoprotein expression under streptozotocin-induced diabetic condition. Biol Pharm Bull 2011; 34:436-8.
Nayeem MA, Zeldin DC, Boegehold MA, Falck JR. Salt modulates vascular response through adenosine A(2A) receptor in eNOS-null mice: role of CYP450 epoxygenase and soluble epoxide hydrolase. Mol Cell Biochem 2011; 350:101-11.
Naz M, Riaz M, Saleem M. Potential role of Neuregulin 1 and TNF-alpha (-308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan. Mol Biol Rep 2011; 38:4709-14.
Nazari ZE, Iranshahi M. Biologically active sesquiterpene coumarins from Ferula species. Phytother Res 2011; 25:315-23.
Nazarian R, Shi H, Wang Q et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 2010; 468:973-7.
Nazar-Stewart V, Vaughan TL, Stapleton P, van Loo J, Nicol-Blades B, Eaton DL. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer 2003; 40:247-58.
Neafsey P, Ginsberg G, Hattis D, Johns DO, Guyton KZ, Sonawane B. Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity. J Toxicol Environ Health B Crit Rev 2009; 12:362-88.
Neale BM, Fagerness J, Reynolds R et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010; 107:7395-400.
Nearman ZP, Szpurka H, Serio B et al. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts. Am J Hematol 2007; 82:1076-9.
Neben K, Mytilineos J, Moehler TM et al. Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood 2002; 100:2263-5.
Nebert DW. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 1997; 60:265-71.
Nebert DW, Adesnik M, Coon MJ et al. The P450 gene superfamily: recommended nomenclature. DNA 1987; 6:1-11.
Nebert DW, Gonzalez FJ. P450 genes: structure, evolution, and regulation. Annu Rev Biochem 1987; 56:945-93.
Nebot N, Crettol S, d’Esposito F, Tattam B, Hibbs DE, Murray M. Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. Br J Pharmacol 2010; 161:1059-69.
Neddens J, Buonanno A. Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 2010; 20:724-44.
Need AC, Keefe RS, Ge D et al. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. Eur J Hum Genet 2009; 17:946-57.
Neff JA, Moody DE. Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4. Biochem Biophys Res Commun 2001; 284:751-6.
Neff MW, Robertson KR, Wong AK et al. Breed distribution and history of canine mdr1-1-delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proc Nat Acad Sci USA 2004; 101:11725-30.
Negash S, Smith GE, Pankratz S et al. Successful aging: definitions and prediction of longevity and conversion to mild cognitive impairment. Am J Geriatr Psychiatry 2011; 19:581-8.
Negishi M, Lindberg R, Burkhart B, Ichikawa T, Honkakoski P, Lang M. Mouse steroid 15-alpha-hydroxylase gene family: identification of type II P450(15-alpha) as coumarin 7-hydroxylase. Biochemistry 1989; 28:4169-72.
Negredo E, Moltó J, Puig J et al. Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins. AIDS 2006; 20:2159-64.
Negri T, Pavan GM, Virdis E et al. T670X KIT mutations in gastrointestinal stromal tumors: making sense of missense. J Natl Cancer Inst 2009; 101:194-204.
Neilan TG, Blake SL, Ichinose F et al. Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin. Circulation 2007; 116:506-14.
Nejatizadeh A, Kumar R, Stobdan T et al. CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension. Clin Biochem 2010; 43:136-41.
Nekvindová J, Masek V, Veinlichová A et al. Inhibition of human liver microsomal cytochrome P450 activities by adefovir and tenofovir. Xenobiotica 2006; 36:1165-77.
Nelson DR, Koymans L, Kamataki T et al. Cytochrome P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics 1996; 6:1-42.
Nelson LS, Erdman AR, Booze LL et al. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 2007; 45:315-32.
Nelson MH, Dolder CR. A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer. Ther Clin Risk Manag 2007; 3:665-73.
Nelson O, Supnet C, Tolia A, Horre K, de Strooper B, Bezprozvanny I. Mutagenesis mapping of presenilin 1 calcium leak conductance pore. J Biol Chem 2011; 286:22339-47.
Nelson O, Tu H, Lei T, Bentahir M, de Strooper B, Bezprozvanny I. Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. J Clin Invest 2007; 117:1230-9.
Nelson TJ, Martinez-Fernandez A, Terzic A. KCNJ11 knockout morula re-engineered by stem cell diploid aggregation. Philos Trans R Soc Lond B Biol Sci 2009; 364:269-76.
Nelson TL, Stevens JR, Hickey MS. Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults. Metabolism 2007; 56:1209-15.
Nemoda Z, Angyal N, Tarnok Z, Gadoros J, Sasvari-Szekely M. Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD. Neuropharmacology 2009; 57:731-3.
Neri T, Merico V, Fiordaliso F et al. The differentiation of cardiomyocytes from mouse embryonic stem cells is altered by dioxin. Toxicol Lett 2011; 202:226-36.
Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008; 82:7264-75.
Netsch MI, Gutmann H, Schmidlin CB, Aydogan C, Drewe J. Induction of CYP1A by green tea extract in human intestinal cell lines. Planta Med 2006; 72:514-20.
Neu P, Seyfert S, Brockmöller J, Dettling M, Marx P. Neuroleptic malignant syndrome in a patient with succinic semialdehyde dehydrogenase deficiency. Pharmacopsychiatry 2002; 35:26-8.
Neubauer H, Günesdogan B, Hanefeld C, Spiecker M, Mügge A. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function-a flow cytometry study. Eur Heart J 2003; 24:1744-9.
Neubauer H, Mügge A. Thienopyridines and statins: assessing a potential drug-drug interaction. Curr Pharm Des 2006; 12:1271-80.
Neufeld EB, Stonik JA, Demosky SJ et al. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem 2004; 279:15571-8.
Neuhausen SL, Mazoyer S, Friedman L et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 1996; 58:271-80.
Neuman RJ, Wasson J, Atzmon G et al. Gene-gene interactions lead to higher risk for development of type 2 diabetes in an Ashkenazi Jewish population. PLoS One 2010. doi:10. 1371/journal. pone. 0009903
Neumann HPH, Bausch B, McWhinney SR et al. Germ-line mutations in nonsyndromic pheochromocytoma. New Eng J Med 2002; 346:1459-66.
Neumann M, Schulz-Schaeffer W, Crowther RA et al. Pick’s disease associated with the novel Tau gene mutation K369I. Ann Neurol 2001; 50:503-13.
Neuvonen AM, Palo JU, Sajantila A. Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users. Int J Legal Med 2011; 125:265-9.
Neuvonen PJ. Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics. Curr Opin Investig Drugs 2010; 11:323-32.
Neuvonen PJ, Backman JT, Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin Pharmacokinet 2008; 47:463-74.
Neuvonen PJ, Jalava KM. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1996; 60:54-61.
Neuvonen PJ, Kantola T, Kivistö KT. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Clin Pharmacol Ther 1998; 63:332-41.
Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 2006; 80:565-81.
Neuwelt AJ, Wu YJ, Knap N et al. Using acetaminophen’s toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines. Neoplasia 2009; 11:1003-11.
Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Molec Brain Res 1986; 1:271-80.
Neves FS, Malloy-Diniz L, Romano-Silva MA et al. The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J Affect Disord 2011; 131:307-11.
Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19 Suppl 1:1-93.
Newhouse S, Farrall M, Wallace C et al. Polymorphisms in the WNK1 gene are associated with blood pressure variation and urinary potassium excretion. PLoS One 2009. doi:10. 1371/journal. pone. 0005003.
Newman MJ, Dixon R, Toyonaga B. OC144-093, a novel P glycoprotein inhibitor for the enhancement of anti-epileptic therapy. Novartis Found Symp 2002; 243:213-35.
Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83:1778-81.
Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 1991; 88:3160-4.
Newman WG, Hadfield KD, Latif A et al. Impaired tamoxifen metabolism reduces survival in familial breast cancer patients. Clin Cancer Res 2008; 14:5913-8.
Newman-Tancredi A, Assié MB, Leduc N, Ormière AM, Danty N, Cosi C. Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia. Int J Neuropsychopharmacol 2005; 8:341-56.
Newmark JR, Hardy DO, Tonb DC et al. Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A 1992; 89:6319-23.
Newton DJ, Wang RW, Lu AY. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 1995; 23:154-8.
Newton-Cheh C, Guo CY, Larson MG et al. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation 2007; 116:1128-36.
Newton-Cheh C, Johnson T, Gateva V et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41:666-76.
Ng CH, Janoo-Gilani R, Sipahimalani P et al. Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma. Cancer Causes Control 2010; 21:11-22.
Ng CH, Mok SZ, Koh C et al. Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J Neurosci 2009; 29:11257-62.
Ng DP. Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies: response to Hadjadj et al. Diabetes Care 2008; 31:78.
Ng J, Sansone RA, McDonald S. Akathisia and abnormal movements of the upper extremities with venlafaxine and methimazole. Gen Hosp Psychiatry 2009; 31:388-90.
Ng MC, Young RP, Critchley JA, Leung NW, Lau JW, Li AK. Urinary 6 beta-hydroxycortisol excretion in Hong Kong Chinese patients with hepatocellular carcinoma and other chronic liver diseases. Cancer 1996; 77:1427-33.
Ngaimisi E, Mugusi S, Minzi O et al. Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis. Clin Pharmacol Ther 2011; 90:406-13.
Ngaimisi E, Mugusi S, Minzi OM et al. Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients. Clin Pharmacol Ther 2010; 88:676-84.
Ngamjanyaporn P, Thakkinstian A, Verasertniyom O et al. Pharmacogenetics of cyclophosphamide and CYP2C19 polymorphism in Thai systemic lupus erythematosus. Rheumatol Int 2010; 31:1215-8.
Ngo N, Brantley SJ, Carrizosa DR et al. The warfarin-cranberry juice interaction revisited: A systematic in vitro-in vivo evaluation. J Exp Pharmacol 2010; 2010:83-91.
Ngui JS, Chen Q, Shou M et al. In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4’- and 10-hydroxywarfarin. Drug Metab Dispos 2001; 29:877-86.
Ngui JS, Tang W, Stearns RA et al. Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine. Drug Metab Dispos 2000; 28:1043-50.
Nguyen D, Dhanasekaran P, Nickel M et al. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry 2010; 49:10881-9.
Nguyen HH, Hannemann F, Hartmann MF, Malunowicz EM, Wudy SA, Bernhardt R. Five novel mutations in CYP11B2 gene detected in patients with aldosterone synthase deficiency type I: Functional characterization and structural analyses. Mol Genet Metab 2010; 100:357-64.
Nguyen KV, Østergaard E, Ravn SH et al. POLG mutations in Alpers syndrome. Neurology 2005; 65:1493-5.
Nguyen KV, Sharief FS, Chan SS, Copeland WC, Naviaux RK. Molecular diagnosis of Alpers syndrome. J Hepatol 2006; 45:108-16.
Nguyen T, Hamby A, Massa SM. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington’s disease mouse model. Proc Natl Acad Sci USA 2005; 102:11840-5.
Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 2005; 45:1157-64.
Nguyen TV, Janssen MJ, van Oijen MG et al. Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population. Oncol Res 2010; 18:349-55.
Nguyêñ GT, Carrington M, Beeler JA et al. Phenotypic expressions of CCR5-delta32/delta32 homozygosity. J Acquir Immune Defic Syndr 1999; 22:75-82.
Ni LN, Li JY, Miao KR et al. Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia. Med Oncol 2011; 28:265-9.
Ni W, Ji J, Dai Z et al. Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. PLoS One 2010. doi:10. 1371/journal. pone. 0013792.
Ni X, Trakalo JM, Mundo E et al. Linkage disequilibrium between dopamine D1 receptor gene (DRD1) and bipolar disorder. Biol Psychiatry 2002; 52:1144-50.
Ni X, Trakalo J, Valente J et al. Human p53 tumor suppressor gene (TP53) and schizophrenia: case-control and family studies. Neurosci Lett 2005; 388:173-8.
Ni Y, Hu D, Yu H et al. Association of genetic polymorphisms in the fibrinogen and platelet glycoprotein genes with unstable angina in Chinese patients. Clin Cardiol 2004; 27:455-8.
Ni Y, Zhao X, Bao G et al. Activation of beta-2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat Med 2006; 12:1390-6.
Ni Z, Bikadi Z, Cai X, Rosenberg MF, Mao Q. Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport. Am J Physiol Cell Physiol 2010; 299:1100-9.
Ni Z, Bikadi Z, Rosenberg MF, Mao Q. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab 2010; 11:603-17.
Ni Z, Mao Q. ATP-binding cassette efflux transporters in human placenta. Curr Pharm Biotechnol 2011; 12:674-85.
Ni Z, Mark ME, Cai X, Mao Q. Fluorescence resonance energy transfer (FRET) analysis demonstrates dimer/oligomer formation of the human breast cancer resistance protein (BCRP/ABCG2) in intact cells. Int J Biochem Mol Biol 2010; 1:1-11.
Ni ZL, Zhao SP, Wu Z. ABCG1-a potential therapeutic target for atherosclerosis. Med Hypotheses 2007; 69:214-7.
Nian WQ, Chen FL, Ao XJ, Chen ZT. CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics. Mol Cell Biochem 2011; 355:241-8.
Nicandro JP, Tsourounis C, Frassetto L, Guglielmo BJ. In vivo effect of I’m-Yunity on hepatic cytochrome P450 3A4. J Herb Pharmacother 2007; 7:39-56.
Nicken P, Hamscher G, Breves G, Steinberg P. Uptake of the colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different segments of the rat gastrointestinal tract: its implication in colorectal carcinogenesis. Toxicol Lett 2010; 196:60-6.
Niclauss N, Michel-Reher MB, Alewijnse AE, Michel MC. Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 2006; 374:99-105.
Nicolakakis N, Hamel E. The nuclear receptor PPARgamma as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer’s disease. Front Aging Neurosci 2010; 2:21.
Nicolas JM, Collart P, Gerin B et al. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Drug Metab Dispos 1999; 27:250-4.
Nicolas JM, Whomsley R, Collart P, Roba J. In vitro inhibition of human liver drug metabolizing enzymes by second generation antihistamines. Chem Biol Interact 1999; 123:63-79.
Nicoletto MO, Bertorelle R, Borgato L et al. Family history of cancer rather than p53 status predicts efficacy of pegylated liposomal doxorubicin and oxaliplatin in relapsed ovarian cancer. Int J Gynecol Cancer 2009; 19:1022-8.
Nicoli R, Bartolini M, Rudaz S, Andrisano V, Veuthey JL. Development of immobilized enzyme reactors based on human recombinant cytochrome P450 enzymes for phase I drug metabolism studies. J Chromatogr A 2008; 1206:2-10.
Nicolo C, Flück CE, Mullis PE, Pandey AV. Restoration of mutant cytochrome P450 reductase activity by external flavin. Mol Cell Endocrinol 2010; 321:245-52.
Nicoll JAR, Burnett C, Love S et al. High frequency of apolipoprotein E epsilon-2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1996; 39:682.
Nicoll JAR, Burnett C, Love S et al. High frequency of apolipoprotein E epsilon-2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997; 41:716-21.
Nicoll JAR, Roberts GW, Graham DI. Apolipoprotein E epsilon-4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med 1995; 1:135-7.
Nichols AI, Fatato P, Shenouda M et al. The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults. J Clin Pharmacol 2009; 49:219-28.
Nichols AI, Focht K, Jiang Q, Preskorn SH, Kane CP. Pharmacokinetics of venlafaxine extended release 75 mg and desvenlafaxine 50 mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study. Clin Drug Investig 2011; 31:155-67.
Nichols AI, Tourian KA, Tse SY, Paul J. Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor. Expert Opin Drug Metab Toxicol 2010; 6:1565-74.
Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: Past, present and future. Differentiation 2011; 82:184-99.
Nicholl BI, Holliday KL, Macfarlane GJ et al. Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: Results from two population-based cohorts. Arthritis Rheum 2011; 63:810-8.
Nicholl DJ, Bennett P, Hiller L et al. A study of five candidate genes in Parkinson’s disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 1999; 53:1415-21.
Nicholl DJ, Greenstone MA, Clarke CE et al. An English kindred with novel recessive taupathy and respiratory failure. Ann Neurol 2003; 54:682-6.
Nie D. Cyclooxygenases and lipoxygenases in prostate and breast cancers. Front Biosci 2007; 12:1574-85.
Nie D, Honn KV. Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell Mol Life Sci 2002; 59:799-807.
Nie L, Li L, Yang L, Zhang Y, Xiao Z. HFE genotype and iron metabolism in Chinese patients with myelodysplastic syndromes and aplastic anemia. Ann Hematol 2010; 89:1249-53.
Nie Q, Yang XN, An SJ et al. CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism. Eur J Cancer2011; 47:1962-70.
Nie SJ, Wen-ru T, Bi-feng C et al. Haplotype-based case-control study of the human AGTR1 gene and essential hypertension in Han Chinese subjects. Clin Biochem 2010; 43:253-8.
Niehof M, Borlak J. Expression of HNF4alpha in the human and rat choroid plexus: implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier. BMC Mol Biol 2009; 10:68.
Niel E, Scherrmann JM. Colchicine today. Joint Bone Spine 2006; 73:672-8.
Nielsen EM, Hansen L, Carstensen B et al. The E23K variant of Kir6. 2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003; 52:573-7.
Nielsen EM, Hansen L, Stissing T et al. Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits. J Mol Med 2005; 83:353-61.
Nielsen KK, Flinois JP, Beaune P, Brøsen K. The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways. J Pharmacol Exp Ther 1996; 277:1659-64.
Nielsen TL, Rasmussen BB, Flinois JP, Beaune P, Brosen K. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes. J Pharmacol Exp Ther 1999; 289:31-7.
Niemelä O, Parkkila S, Juvonen RO, Viitala K, Gelboin HV, Pasanen M. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J Hepatol 2000; 33:893-901.
Niemi M. Transporter pharmacogenetics and statin toxicity. Clin Pharmacol Ther 2010; 87:130-3.
Niemi M, Arnold KA, Backman JT et al. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Pharmacogenet Genomics 2006; 16:801-8.
Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivistö KT. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42:819-50.
Niemi M, Backman JT, Juntti-Patinen L, Neuvonen M, Neuvonen PJ. Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide. Br J Clin Pharmacol 2005; 60:208-17.
Niemi M, Backman JT, Kajosaari LI et al. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clin Pharmacol Ther 2005; 77:468-78.
Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivistö KT. Rifampin decreases the plasma concentrations and effects of repaglinide. Clin Pharmacol Ther 2000; 68:495-500.
Niemi M, Cascorbi I, Timm R, Kroemer HK, Neuvonen PJ, Kivistö KT. Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes. Clin Pharmacol Ther 2002; 72:326-32.
Niemi M, Kivistö KT, Diczfalusy U et al. Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin. Pharmacogenet Genomics 2006; 16:565-8.
Niemi M, Neuvonen PJ, Kivistö KT. The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide. Clin Pharmacol Ther 2001; 70:58-65.
Niemi M, Tornio A, Pasanen MK, Fredrikson H, Neuvonen PJ, Backman JT. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide. Eur J Clin Pharmacol 2006; 62:463-72.
Niemiec P, Zak I, Wita K. The M235T polymorphism of the AGT gene modifies the risk of coronary artery disease associated with the presence of hypercholesterolemia. Eur J Epidemiol 2008; 23:349-54.
Nieminen T, Lehtimäki T, Mäenpää J, Ropo A, Uusitalo H, Kähönen M. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest 2007; 67:237-45.
Nieminen T, Uusitalo H, Mäenpää J et al. Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study. Eur J Clin Pharmacol 2005; 61:811-9.
Nieminen TH, Hagelberg NM, Saari TI et al. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone. Anesthesiology 2009; 110:1371-8.
Nieminen TH, Hagelberg NM, Saari TI et al. Grapefruit juice enhances the exposure to oral oxycodone. Basic Clin Pharmacol Toxicol 2010; 107:782-8.
Niemira M, Wiśniewska A, Mazerska Z. Polymorphism and the level of P450 gene expression in xenobiotic metabolism. Postepy Biochem 2009; 55:279-89.
Niesler B, Flohr T, Nöthen MM et al. Association between the 5’ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 2001; 11:471-5.
Niesler B, Kapeller J, Hammer C, Rappold G. Serotonin type 3 receptor genes: HTR3A, B, C, D, E. Pharmacogenomics 2008; 9:501-4.
Niesler B, Weiss B, Fischer C et al. Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics 2001; 11:21-7.
Niessen NA, Balthazart J, Ball GF, Charlier TD. Steroid receptor coactivator 2 (SRC-2) modulates steroid-dependent male sexual behavior and neuroplasticity in Japanese Quail (Coturnix Japonica). J Neurochem 2011; 119:579-93.
Niestroy J, Barbara A, Herbst K, Rode S, van Liempt M, Roos PH. Single and concerted effects of benzo[a]pyrene and flavonoids on the AhR and Nrf2-pathway in the human colon carcinoma cell line Caco-2. Toxicol In Vitro 2011; 25:671-83.
Nieto A, Goldfarb LG, Brown P et al. Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet 1991; 337:622-3.
Nieto N, Friedman SL, Cederbaum AI. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 2002; 35:62-73.
Nieto N, Friedman SL, Cederbaum AI. Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells. J Biol Chem 2002; 277:9853-64.
Nieuwenhuis B, Lüth A, Chun J et al. Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone. J Mol Med 2009; 87:645-57.
Nievergelt A, Huonker P, Schoop R, Altmann KH, Gertsch J. Identification of serotonin 5-HT1A receptor partial agonists in ginger. Bioorg Med Chem 2010; 18:3345-51.
Nigg HN, Knaak JB. Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure. Rev Environ Contam Toxicol 2000; 163:29-111.
Nigro P, Satoh K, O’Dell MR et al. Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2011; 208:53-66.
Niino M, Kikuchi S, Fukazawa T, Yabe I, Tashiro K. Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis. Mult Scler 2003; 9:382-6.
Niioka T, Uno T, Yasui-Furukori N, Shimizu M, Sugawara K, Tateishi T. Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve. Eur J Clin Pharmacol 2006; 62:855-61.
Niioka T, Yasui-Furukori N, Uno T, Sugawara K, Kaneko S, Tateishi T. Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve. Ther Drug Monit 2006; 28:321-5.
Nikisch G, Baumann P, Oneda B et al. Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study. J Psychopharmacol 2011; 25:896-907.
Nikisch G, Eap CB, Baumann P. Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study. Pharmacol Res 2008; 58:344-7.
Nikkari ST, Henttonen A, Kunnas T et al. Estrogen receptor 2 polymorphism and carotid intima-media thickness. Genet Test 2008; 12:537-40.
Nikles D, Bach P, Boller K et al. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. J Virol 2005; 79:4033-42.
Nikolov IG, Joki N, Nguyen-Khoa T et al. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice. Nephrol Dial Transplant 2011. doi:10. 1093/ndt/gfr254.
Nikolova PN, Ivanova MI, Mihailova SM et al. Cytokine gene polymorphism in kidney transplantation-impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome. Transpl Immunol 2008; 18:344-8.
Nilsson LM, Sjövall J, Strom S et al. Ethanol stimulates bile acid formation in primary human hepatocytes. Biochem Biophys Res Commun 2007; 364:743-7.
Nimz M, Spitschak M, Fürbass R, Vanselow J. The pre-ovulatory luteinizing hormone surge is followed by down-regulation of CYP19A1, HSD3B1, and CYP17A1 and chromatin condensation of the corresponding promoters in bovine follicles. Mol Reprod Dev 2010; 77:1040-8.
Ning M, Yang Y, Zhang Z et al. Amyloid-beta-Related Genes SORL1 and ACE are Genetically Associated With Risk for Late-onset Alzheimer Disease in the Chinese Population. Alzheimer Dis Assoc Disord 2010; 24:390-6.
Ning YX, Ren SL, Zhao FD, Yin LH. Overexpression of the steroidogenic acute regulatory protein increases the expression of ATP-binding cassette transporters in microvascular endothelial cells (bEnd. 3). J Zhejiang Univ Sci B 2010; 11:350-6.
Ninomiya H, Mamiya K, Matsuo S, Ieiri I, Higuchi S, Tashiro N. Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication. Ther Drug Monit 2000; 22:230-2.
Nirogi R, Kandikere V, Bhyrapuneni G, Ponnamaneni RK, Palacharla RC, Manoharan AK. Effect of dimethyl sulfoxide on in vitro cytochrome P450 1A2 mediated phenacetin-o-deethylation in human liver microsomes. Drug Metab Dispos 2011; 39:2162-4.
Nisemblat Y, Belinson H, Dolev I, Michaelson DM. Activation of the amyloid cascade by intracerebroventricular injection of the protease inhibitor phosphoramidon. Neurodegener Dis 2008; 5:166-9.
Nishanth RP, Ramakrishna BS, Jyotsna RG et al. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line. Eur J Pharmacol 2010; 649:74-83.
Nishi K, Ishii T, Wada M et al. The expression of intestinal CYP3A4 in the piglet model. Transplant Proc 2004; 36:361-3.
Nishida H, Hirai H, Emoto C, Iwasaki K. Metabolism of CJ-036878, N-(3-phenethoxybenzyl)-4-hydroxybenzamide, in liver microsomes and recombinant cytochrome P450 enzymes: metabolite identification by LC-UV/MS(n) and (1)H-NMR. Xenobiotica 2007; 37:1394-407.
Nishida M, Fujinaka H, Matsusaka T et al. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 2002; 110:1859-68.
Nishida T, Yu JD, Minamishima S et al. Protective effects of nitric oxide synthase 3 and soluble guanylate cyclase on the outcome of cardiac arrest and cardiopulmonary resuscitation in mice. Crit Care Med 2009; 37:256-62.
Nishida Y, Fukuda T, Yamamoto I, Azuma J. CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10. Pharmacogenetics 2000; 10:567-70.
Nishigaki R, Totsuka Y, Takamura-Enya T, Sugimura T, Wakabayashi K. Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline. Mutat Res 2004; 562:19-25.
Nishii N, Ogawa M, Morita H et al. SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome. Circ J 2010; 74:2572-8.
Nishikawa H, Inoue T, Izumi T, Koyama T. Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats. Eur Neuropsychopharmacol 2007; 17:643-50.
Nishikawa H, Inoue T, Masui T, Izumi T, Koyama T. Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:926-31.
Nishikawa H, Inoue T, Masui T, Izumi T, Nakagawa S, Koyama T. Pharmacokinetic interaction between tandospirone and fluvoxamine in the rat contextual conditioned fear stress model and its functional consequence: Involvement of cytochrome P450 3A4. Psychiatry Clin Neurosci 2008; 62:591-6.
Nishikawa M, Ariyoshi N, Kotani A et al. Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab Pharmacokinet 2004; 19:280-9.
Nishikawa T, Matsuzawa Y, Suematsu S, Saito J, Omura M, Kino T. Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells. Arzneimittelforschung 2010; 60:445-51.
Nishimune A, Suzuki F, Yoshiki H, Morishima S, Muramatsu I. Alpha 1-adrenoceptor pharmacome: alpha 1L-adrenoceptor and alpha 1A-adrenoceptor in the lower urinary tract. Int J Urol 2010; 17:31-7.
Nishimura FT, Kimura Y, Abe S, Fukunaga T, Saijoh K. Effects of polymorphisms in untranslated regions of the class I alcohol dehydrogenase (ADH) genes on alcohol metabolism in Japanese subjects and transcriptional activity in HepG2 cells. Nihon Arukoru Yakubutsu Igakkai Zasshi 2009; 44:139-55.
Nishimura M, Imai T, Morioka Y, Kuribayashi S, Kamataki T, Naito S. Effects of NO-1886 (Ibrolipim), a lipoprotein lipase-promoting agent, on gene induction of cytochrome P450s, carboxylesterases, and sulfotransferases in primary cultures of human hepatocytes. Drug Metab Pharmacokinet 2004; 19:422-9.
Nishimura M, Koeda A, Suganuma Y et al. Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Drug Metab Pharmacokinet 2007; 22:178-86.
Nishimura M, Naito S, Yokoi T. Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug Metab Pharmacokinet 2004; 19:135-49.
Nishimura M, Narimatsu S, Naito S. Evaluation of induction potency of new drug candidates on CYP1A2 and CYP3A4 using real-time one-step RT-PCR in primary cultures of cryopreserved human hepatocytes. Drug Metab Pharmacokinet 2009; 24:446-50.
Nishimura M, Ueda N, Naito S. Effects of dimethyl sulfoxide on the gene induction of cytochrome P450 isoforms, UGT-dependent glucuronosyl transferase isoforms, and ABCB1 in primary culture of human hepatocytes. Biol Pharm Bull 2003; 26:1052-6.
Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 2003; 123:369-75.
Nishimura M, Yokoi T, Tateno C et al. Induction of human CYP1A2 and CYP3A4 in primary culture of hepatocytes from chimeric mice with humanized liver. Drug Metab Pharmacokinet 2005; 20:121-6.
Nishimura M, Yoshitsugu H, Naito S, Hiraoka I. Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 2002; 122:339-61.
Nishimuta H, Sato K, Mizuki Y, Yabuki M, Komuro S. Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans. Drug Metab Pharmacokinet 2011; 26:300-6.
Nishino M, Sugimoto M, Kodaira C et al. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers. J Clin Pharmacol 2011; 51:1079-86.
Nishio H, Kuwahara M, Tsubone H et al. Identification of an ethnic-specific variant (V207M) of the KCNQ1 cardiac potassium channel gene in sudden unexplained death and implications from a knock-in mouse model. Int J Legal Med 2009; 123:253-7.
Nishio M, Endo T, Fujimoto K et al. FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin’s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. Eur J Haematol 2009; 82:143-7.
Nishio S, Watanabe H, Kosuge K, Uchida S, Hayashi H, Ohashi K. Interaction between amlodipine and simvastatin in patients with hypercholesterolemia and hypertension. Hypertens Res 2005; 28:223-7.
Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem 2011; 286:17536-42.
Nishitsuji K, Hosono T, Uchimura K, Michikawa M. Lipoprotein lipase is a novel amyloid beta (Abeta)-binding protein that promotes glycosaminoglycan-dependent cellular uptake of Abeta in astrocytes. J Biol Chem 2011; 286:6393-401.
Nishiuchi Y, Murao K, Imachi H, Nishiuchi T, Iwama H, Ishida T. Transcriptional factor prolactin regulatory element-binding protein-mediated gene transcription of ABCA1 via 3’,5’-cyclic adenosine-5’-monophosphate. Atherosclerosis 2010; 212:418-25.
Nishiya Y, Nakamura K, Okudaira N, Abe K, Kobayashi N, Okazaki O. Effects of organic solvents on the time-dependent inhibition of CYP3A4 by diazepam. Xenobiotica 2010; 40:1-8.
Nishiyama T, Ohnuma T, Inoue Y, Kishi T, Ogura K, Hiratsuka A. UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation. Biochem Biophys Res Commun 2008; 371:247-50.
Niskanen L, Karvonen MK, Valve R et al. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab 2000; 85:2266-9.
Nisoli E, Tonello C, Cardile A et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310:314-17.
Nissen SE, Tsunoda T, Tuzcu EM et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290:2292-300.
Nissenbaum J, Devor M, Seltzer Z et al. Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res 2010; 20:1180-90.
Nisticò L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996; 5:1075-80.
Nithipatikom K, Brody DM, Tang AT et al. Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists. Cancer Sci 2010; 101:2629-36.
Nitrini R, Rosenberg S, Passos-Bueno MR et al. Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 1997; 42:138-46.
Nitschke Y, Weissen-Plenz G, Terkeltaub R, Rutsch F. Npp1 promotes atherosclerosis in ApoE knockout mice. J Cell Mol Med 2011. doi:10. 1111/j. 1582-4934. 2011. 01327. x.
Niu MJ, Yang JK, Lin SS, Ji XJ, Guo LM. Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine 2008; 34:56-61.
Niu RJ, Zheng QC, Zhang JL, Zhang HX. Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods. J Mol Model 2011. doi:10. 1007/s00894-011-0970-2.
Niu W, Gao P, Zhu D. Haplotype-based case-control study of the human CYP4F2 gene and essential hypertension in Japanese subjects. Hypertens Res 2009; 32:529.
Niu W, Qi Y, Gao P, Zhu D. Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis. Endocr J 2010; 57:431-8.
Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens 2009; 27:1384-91.
Niu W, Qi Y, Hou S, Zhou W, Qiu C. Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese Transl Res 2007; 150:374-80.
Niu W, Qi Y. Association of the angiotensin II type I receptor gene +1166 A>C polymorphism with hypertension risk: evidence from a meta-analysis of 16474 subjects. Hypertens Res 2010; 33:1137-43.
Niu WQ, Qi Y. Meta-based evidence for apolipoprotein E ε2/ε3/ε4 polymorphism in association with hypertension among Chinese. J Hum Hypertens 2011. doi:10. 1038/jhh. 2010. 116.
Niu WQ, Zhang Y, Ji KD, Gao PJ, Zhu DL. Lack of association between alpha-adducin G460W polymorphism and hypertension: evidence from a case-control study and a meta-analysis. J Hum Hypertens 2010; 24:467-74.
Niu XL, Madamanchi NR, Vendrov AE et al. Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation 2010; 121:549-59.
Niu Y, Hu Y, Wu M et al. CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis. Mol Biol Rep 2011. doi:10. 1007/s11033-011-0777-3
Niu Y, Yuan H, Leng W, Pang Y, Gu N, Chen N. CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls. Med Oncol 2011; 28:182-7.
Nivoix Y, Levêque D, Herbrecht R, Koffel JC, Beretz L, Ubeaud-Sequier G. The enzymatic basis of drug-drug interactions with systemic triazole antifungals. Clin Pharmacokinet 2008; 47:779-92.
Niwa T, Fujimoto M, Kishimoto K, Yabusaki Y, Ishibashi F, Katagiri M. Metabolism and interaction of bisphenol A in human hepatic cytochrome P450 and steroidogenic CYP17. Biol Pharm Bull 2001; 24:1064-7.
Niwa T, Inoue S, Shiraga T, Takagi A. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug. Biol Pharm Bull 2005; 28:188-91.
Niwa T, Inoue-Yamamoto S, Shiraga T, Takagi A. Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes. Biol Pharm Bull 2005; 28:1813-6.
Niwa T, Maekawa Y, Fujimoto M et al. Inhibition of human hepatic cytochrome P450s and steroidogenic CYP17 by nonylphenol. Biol Pharm Bull 2002; 25:235-8.
Niwa T, Murayama N, Emoto C, Yamazaki H. Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5. Curr Drug Metab 2008; 9:20-33.
Niwa T, Murayama N, Umeyama H, Shimizu M, Yamazaki H. Human liver enzymes responsible for metabolic elimination of tyramine; a vasopressor agent from daily food. Drug Metab Lett 2011; 5:216-9.
Niwa T, Murayama N, Yamazaki H. Heterotropic cooperativity in oxidation mediated by cytochrome p450. Curr Drug Metab 2008; 9:453-62.
Niwa T, Murayama N, Yamazaki H. Oxidation of endobiotics mediated by Xenobiotic-metabolizing forms of human cytochrome P450. Curr Drug Metab 2009; 10:700-12.
Niwa T, Murayama N, Yamazaki H. Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition. Curr Drug Metab 2011; 12:412-35.
Niwa T, Okada K, Hiroi T, Imaoka S, Narimatsu S, Funae Y. Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain. Biol Pharm Bull 2008; 31:348-51.
Niwa T, Sato R, Yabusaki Y, Ishibashi F, Katagiri M. Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine. Xenobiotica 1999; 29:187-93.
Niwa T, Shiraga T, Hashimoto T, Kagayama A. Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes. Biol Pharm Bull 2004; 27:97-9.
Niwa T, Shiraga T, Hashimoto T, Kagayama A. Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes. Biol Pharm Bull 2004; 27:415-7.
Niwa T, Shiraga T, Ishii I, Kagayama A, Takagi A. Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs. Biol Pharm Bull 2005; 28:1711-6.
Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Drug Metab Dispos 2000; 28:1128-34.
Niwa T, Shiraga T, Takagi A. Drug-drug interaction of antifungal drugs. Yakugaku Zasshi 2005; 125:795-805.
Niwa T, Shiraga T, Takagi A. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 2005; 28:1805-8.
Niwa T, Shiraga T, Yamasaki S, Ishibashi K, Ohno Y, Kagayama A. In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica 2003; 33:717-29.
Niwa T, Tsutsui M, Kishimoto K, Yabusaki Y, Ishibashi F, Katagiri M. Inhibition of drug-metabolizing enzyme activity in human hepatic cytochrome P450s by bisphenol A. Biol Pharm Bull 2000; 23:498-501.
Niwa T, Yabusaki Y, Honma K et al. Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 1998; 28:539-47.
Niwa T, Yamamoto S, Saito M et al. Effects of serotonin-3 receptor antagonists on cytochrome P450 activities in human liver microsomes. Biol Pharm Bull 2006; 29:1931-5.
Niwa T, Yamamoto S, Saito M, Shiraga T, Takagi A. Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. Yakugaku Zasshi 2007; 127:209-16.
N’jai AU, Larsen MC, Bushkofsky JR, Czuprynski CJ, Jefcoate CR. Acute disruption of bone marrow hematopoiesis by benzo(a)pyrene is selectively reversed by aryl hydrocarbon receptor-mediated processes. Mol Pharmacol 2011; 79:724-34.
Njålsson R, Norgren S. Physiological and pathological aspects of GSH metabolism. Acta Paediatr 2005; 94:132-7.
Njålsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S. Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency. Hum Genet 2005; 116:384-9.
Njoku DB. Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: a review. Expert Opin Drug Metab Toxicol 2010; 6:519-31.
Noble EP. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 1998; 16:33-45.
Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 2000; 15:79-89.
Noble W, Olm V, Takata K et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 2003; 38:555-65.
Nobusawa S, Lachuer J, Wierinckx A et al. Intratumoral patterns of genomic imbalance in glioblastomas. Brain Pathol 2010; 20:936-44.
Nock NL, Tang D, Rundle A et al. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol Biomarkers Prev 2007; 16:1236-45.
Noda T, Abe F, Ueyama J et al. Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats. J Infect Chemother 2011; 17:207-13.
Nofer J-R, Herminghaus G, Brodde M et al. Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease). J Biol Chem 2004; 279:34032-7.
Nogal A, Coelho A, Catarino R, Morais A, Lobo F, Medeiros R. The CYP3A4 *1B polymorphism and prostate cancer susceptibility in a Portuguese population. Cancer Genet Cytogenet 2007; 177:149-52.
Noguchi K, Katayama K, Mitsuhashi J, Sugimoto Y. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv Drug Deliv Rev 2009; 61:26-33.
Noguchi K, Kawahara H, Kaji A, Katayama K, Mitsuhashi J, Sugimoto Y. Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib. Cancer Sci 2009; 100:1701-7.
Noguchi S. Predictive factors for response to docetaxel in human breast cancers. Cancer Sci 2006; 97:813-20.
Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer’s disease. Lancet 1993; 342:737.
Nogueira CP, Bartels CF, McGuire MC et al. Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase. Am J Hum Genet 1992; 51:821-8.
Nogueira EF, Gerry D, Mantero F, Mariniello B, Rainey WE. The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol 2010; 73:22-9.
Nogueira EF, Rainey WE. Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology 2010; 151:1060-70.
Noh JR, Kim YH, Gang GT et al. Hepatoprotective effects of chestnut (Castanea crenata) inner shell extract against chronic ethanol-induced oxidative stress in C57BL/6 mice. Food Chem Toxicol 2011; 49:1537-43.
Noh K, Seo YM, Lee SK et al. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats. Arch Pharm Res 2011; 34:119-25.
Nolin TD, Appiah K, Kendrick SA, Le P, McMonagle E, Himmelfarb J. Hemodialysis acutely improves hepatic CYP3A4 metabolic activity. J Am Soc Nephrol 2006; 17:2363-7.
Nolin TD, Gastonguay MR, Bies RR, Matzke GR, Frye RF. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies. Clin Pharmacol Ther 2003; 74:555-68.
Nolting A, Abramowitz W. Lack of interaction between citalopram and the CYP3A4 substrate triazolam. Pharmacotherapy 2000; 20:750-5.
Nomiyama T, Tanaka Y, Piao L et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 2003; 48:138-41.
Nomoto M, Nakatsuka A, Nagai M et al. Inter- and intraindividual pharmacokinetic variations in the treatment of Parkinson’s disease. Rinsho Shinkeigaku 2005; 45:895-8.
Nomura M, Shigematsu H, Li L et al. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. PLoS Med 2007. doi:10. 1371/journal. pmed. 0040125.
Nonaka T, Takakuwa K, Tanaka K. Analysis of the polymorphisms of genes coding biotransformation enzymes in recurrent miscarriage in the Japanese population. J Obstet Gynaecol Res 2011; 37:1352-8.
Nonomura K, Arai Y, Mitani H, Abe-Dohmae S, Yokoyama S. Insulin down-regulates specific activity of ATP-binding cassette transporter A1 for high density lipoprotein biogenesis through its specific phosphorylation. Atherosclerosis 2011; 216:334-41.
Noppers I, Olofsen E, Niesters M et al. Effect of rifampicin on S-ketamine and S-norketamine plasma concentrations in healthy volunteers after intravenous S-ketamine administration. Anesthesiology 2011; 114:1435-45.
Noracharttiyapot W, Nagai Y, Matsubara T et al. Construction of several human-derived stable cell lines displaying distinct profiles of CYP3A4 induction. Drug Metab Pharmacokinet 2006; 21:99-108.
Norat T, Bowman R, Luben R et al. Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study. Am J Clin Nutr 2008; 88:392-7.
Nordberg A, Amberla K, Shigeta M et al. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities. Alzheimer Dis Assoc Disord 1998; 12:228-37.
Nordberg A, Darreh-Shori T, Peskind E et al. Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Curr Alzheimer Res 2009; 6:4-14.
Nordenskjöld A, Ivarsson SA. Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family. J Clin Endocrinol Metab 1998; 83:3236-8.
Nordestgaard BG, Kontula K, Benn M et al. Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study. Pharmacogenet Genomics 2010; 20:77-85.
Nordin C, Bertilsson L. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline. Clin Pharmacokinet 1995; 28:26-40.
Nordin C, Dahl ML, Eklundh T, Eriksson M, Sjöberg S. CSF taurine level is influenced by plasma cholesterol and the CYP2D6 phenotype. Eur Neuropsychopharmacol 2003; 13:333-5.
Noreault TL, Kostrubsky VE, Wood SG et al. Arsenite decreases CYP3A4 and RXRalpha in primary human hepatocytes. Drug Metab Dispos 2005; 33:993-1003.
Noris M, Caprioli J, Bresin E et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5:1844-59.
Norlén M, Allard P. Reduction in number of dopamine uptake sites but unchanged number of piperazine-acceptor/CYP450IID6 binding sites in the human caudate nucleus in aging. Neurosci Lett 1996; 209:161-4.
Norlin M, Pettersson H, Tang W, Wikvall K. Androgen receptor-mediated regulation of the anti-atherogenic enzyme CYP27A1 involves the JNK/c-jun pathway. Arch Biochem Biophys 2011; 506:236-41.
Norlin M, Wikvall K. Enzymes in the conversion of cholesterol into bile acids. Curr Mol Med 2007; 7:199-218.
Noroozianavval M, Argani H, Aghaeishahsavari M et al. Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril. Transplant Proc 2007; 39:1018-22.
Norris MD, Smith J, Tanabe K et al. Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Mol Cancer Ther 2005; 4:547-53.
Northwood EL, Elliott F, Forman D et al. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. Pharmacogenet Genomics 2010; 20:315-26.
Norton GR, Brooksbank R, Woodiwiss AJ. Gene variants of the renin-angiotensin system and hypertension: from a trough of disillusionment to a welcome phase of enlightenment? Clin Sci 2010; 118:487-506.
Norton N, Moskvina V, Morris DW et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006; 141:96-101.
Norton N, Owen MJ. HTR2A: association and expression studies in neuropsychiatric genetics. Ann Med 2005; 37:121-9.
Norton N, Williams HJ, Dwyer S et al. No evidence for association between polymorphisms in GRM3 and schizophrenia. BMC Psychiatry 2005; 5:23.
Nosheen M, Ishrat M, Malik FA, Baig RM, Kayani MA. Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev 2010; 11:881-5.
Nossaman VE, Ramadhyani U, Kadowitz PJ, Nossaman BD. Advances in perioperative pain management: use of medications with dual analgesic mechanisms, tramadol & tapentadol. Anesthesiol Clin 2010; 28:647-66.
Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation 2003; 108:1804-8.
Novelli G, Margiotti K, Chiocca AM, Spera E, Micali F, Reichardt JK. Pharmacogenetics of human androgens and prostate cancer-an update. Pharmacogenomics 2004; 5:283-94.
Nowak D, Ogawa S, Müschen M et al. SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations. Blood 2010; 115:1049-53.
Nowak I, Malinowski A, Tchórzewski H et al. HLA-C C1C2 heterozygosity may protect women bearing the killer immunoglobulin-like receptor AA genotype from spontaneous abortion. J Reprod Immunol 2011; 88:32-7.
Nowak SN, Edwards DJ, Clarke A, Anderson GD, Jaber LA. Pioglitazone: effect on CYP3A4 activity. J Clin Pharmacol 2002; 42:1299-302.
Nozawa H. Xanthohumol, the chalcone from beer hops (Humulus lupulus L. ), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochem Biophys Res Commun 2005; 336:754-61.
Nozawa H, Oda E, Ueda S et al. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer. Int J Cancer 1998; 77:522-7.
Nozawa M, Ohnuma T, Matsubara Y et al. The relationship between the response of clinical symptoms and plasma olanzapine concentration, based on pharmacogenetics: Juntendo University Schizophrenia Projects (JUSP). Ther Drug Monit 2008; 30:35-40.
Nozawa T, Taguchi M, Tahara K et al. Influence of CYP2D6 genotype on metoprolol plasma concentration and beta-adrenergic inhibition during long-term treatment: a comparison with bisoprolol. J Cardiovasc Pharmacol 2005; 46:713-20.
Nozue T, Higashikata T, Inazu A et al. Identification of a novel missense mutation in the sterol 27-hydroxylase gene in two Japanese patients with cerebrotendinous xanthomatosis. Intern Med 2010; 49:1127-31.
Ntalla I, Dedoussis G, Yannakoulia M et al. ADIPOQ gene polymorphism rs1501299 interacts with fibre intake to affect adiponectin concentration in children: the GENe-Diet Attica Investigation on childhood obesity. Eur J Nutr 2009; 48:493-7.
Ntukidem NI, Nguyen AT, Stearns V et al. Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin Pharmacol Ther 2008; 83:702-10.
Nukatsuka M, Saito H, Nakagawa F et al. Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts. Breast Cancer Res Treat 2011; 128:381-90.
Nukaya M, Lin BC, Glover E, Moran SM, Kennedy GD, Bradfield CA. The aryl hydrocarbon receptor-interacting protein (AIP) is required for dioxin-induced hepatotoxicity but not for the induction of the Cyp1a1 and Cyp1a2 genes. J Biol Chem 2010; 285:35599-605.
Nukaya M, Moran S, Bradfield CA. The role of the dioxin-responsive element cluster between the Cyp1a1 and Cyp1a2 loci in aryl hydrocarbon receptor biology. Proc Natl Acad Sci USA 2009; 106:4923-8.
Nukui T, Day RD, Sims CS, Ness RB, Romkes M. Maternal/newborn GSTT1 null genotype contributes to risk of preterm, low birthweight infants. Pharmacogenetics 2004; 14:569-76.
Nunoya K, Yokoi T, Kimura K et al. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502). Pharmacogenetics 1998; 8:239-49.
Nunoya K, Yokoi T, Takahashi Y, Kimura K, Kinoshita M, Kamataki T. Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype. J Biochem 1999; 126:402-7.
Nunoya KI, Yokoi T, Kimura K et al. A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans. J Pharmacol Exp Ther 1999; 289:437-42.
Nurchi VM, Lachowicz JI, Crisponi G et al. Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III). Dalton Trans 2011; 40:5984-98.
Nurmohamed L, Garcia-Bournissen F, Buono RJ, Shannon MW, Finkelstein Y. Predisposition to epilepsy-does the ABCB1 gene play a role? Epilepsia 2010; 51:1882-5.
Nürnberger J, Dammer S, Mitchell A et al. Effect of the C825T polymorphism of the G protein beta 3 subunit on the systolic blood pressure-lowering effect of clonidine in young, healthy male subjects. Clin Pharmacol Ther 2003; 74:53-60.
Nussbaum J, Xu Q, Payne TJ et al. Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. Hum Mol Genet 2008; 17:1569-77.
Nyabi O, Bentahir M, Horre K et al. Presinilins mutated at Asp-257 or Asp-385 Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem 2003; 278:433430-6.
Nyagode BA, Lee CM, Morgan ET. Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice. J Pharmacol Exp Ther 2010; 335:480-8.
Nyberg S, Dahl ML, Halldin C. A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone. Psychopharmacology 1995; 119:345-8.
Nygren P, Hande K, Petty KJ et al. Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients. Cancer Chemother Pharmacol 2005; 55:609-16.
Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG. QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine. Ann Pharmacother 2005; 39:543-6.
Nyunt MM, Becker S, MacFarland RT et al. Pharmacokinetic effect of AMD070, an Oral CXCR4 antagonist, on CYP3A4 and CYP2D6 substrates midazolam and dextromethorphan in healthy volunteers. J Acquir Immune Defic Syndr 2008; 47:559-65.
Nyunt O, Wu JY, McGown IN et al. Investigating maturity onset diabetes of the young. Clin Biochem Rev 2009; 30:67-74.
